A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Public ClinicalTrials.gov record NCT07023731. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of ARV-806 in Participants With KRAS G12D Mutated Advanced Solid Tumors
Study identification
- NCT ID
- NCT07023731
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Arvinas Inc.
- Industry
- Enrollment
- 159 participants
Conditions and interventions
Conditions
Interventions
- ARV-806 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 28, 2025
- Primary completion
- Nov 29, 2027
- Completion
- Apr 1, 2029
- Last update posted
- Feb 18, 2026
2025 – 2029
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Trial Site | Phoenix | Arizona | 85004 | Recruiting |
| Clinical Trial Site | Phoenix | Arizona | 85054 | Recruiting |
| Clinical Trial Site | New Haven | Connecticut | 06510 | Recruiting |
| Clinical Trial Site | Tampa | Florida | 33612 | Recruiting |
| Clinical Trial Site | Indianapolis | Indiana | 46250 | Not yet recruiting |
| Clinical Trial Site | Grand Rapids | Michigan | 49546 | Recruiting |
| Clinical Trial Site | New York | New York | 10032 | Recruiting |
| Clinical Trial Site | New York | New York | 10065 | Recruiting |
| Clinical Trial Site | Huntersville | North Carolina | 28078 | Recruiting |
| Clinical Trial Site | Cleveland | Ohio | 44106 | Recruiting |
| Clinical Trial Site | Houston | Texas | 77030-7009 | Recruiting |
| Clinical Trial Site | San Antonio | Texas | 78229 | Recruiting |
| Clinical Trial Site | Salt Lake City | Utah | 84112 | Recruiting |
| Clinical Trial Site | Fairfax | Virginia | 22031 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07023731, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 18, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07023731 live on ClinicalTrials.gov.